• Chart
  • F&O
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Alkem Share Price

    Alkem Laboratories Share PriceAlkem Laboratories

    Large Cap 6.3k Result
    ₹4,647.9
    -75.65 (-1.6%)
    • Advice
    • Hold
    As on 04 December, 2023 | 02:54 BSE: 539523 NSE: ALKEMISIN: INE540L01014

    Alkem Laboratories Performance

    Day Range

    • Low 4,621.75
    • High 4,741.95
    ₹ 4,647.9

    52 Week Range

    • Low 2,940.05
    • High 4,795.50
    ₹ 4,647.9
    • Open Price4,724.90
    • Previous Close4,723.55
    • Volume264101

    Start SIP in Alkem Laboratories

    Start SIP

    Alkem Laboratories Share Price

    • Over 1 Month 24.85%
    • Over 3 Month 28.58%
    • Over 6 Month 37.5%
    • Over 1 Year 48.49%

    Alkem Laboratories Key Statistics

    P/E Ratio 38.8
    PEG Ratio 1.2
    Market Cap Cr 55,573
    Price to Book Ratio 5.9
    EPS 95.7
    Dividend 1.1
    Relative Strength Index 77.8
    Money Flow Index 82.69
    MACD Signal 210.17
    Average True Range 98.82

    Alkem Laboratories F&O

    Alkem Laboratories Futures
    Alkem Laboratories Option Chain

    Alkem Laboratories Investment Rating

    • Master Rating:

    • Alkem Laboratories has an operating revenue of Rs. 12,351.40 Cr. on a trailing 12-month basis. An annual revenue growth of 9% is good, Pre-tax margin of 11% is healthy, ROE of 10% is good. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 19% and 29% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 9% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 90 which is a GREAT score indicating consistency in earnings, a RS Rating of 70 which is FAIR indicating the recent price performance, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 72 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Alkem Laboratories Financials
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 2,6352,2532,2382,2972,4612,0582,006
    Operating Expenses Qtr Cr 1,9801,9191,9061,8412,0561,8751,807
    Operating Profit Qtr Cr 655334332456406183200
    Depreciation Qtr Cr 59585758585755
    Interest Qtr Cr 19212223202213
    Tax Qtr Cr -84775475120109
    Net Profit Qtr Cr 64727125538935114077
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 9,3219,030
    Operating Expenses Annual Cr 7,6787,019
    Operating Profit Annual in Cr 1,3771,810
    Depreciation Cr 230219
    Interest Annual Cr 8638
    Tax Annual Cr 193212
    Net Profit Annual Cr 1,1341,541
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 1,299
    Cash from Investing Activity Annual Cr -1,669
    Cash from Financing Annual Activity Cr 437
    Net Cash Flow Annual Cr 67
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 9,3508,744
    Fixed Assets Annual Cr 2,0542,115
    Total Non Current Assets Annual Cr 5,9596,309
    Total Current Assets Annual Cr 6,7726,861
    Total Assets Annual Cr 12,73113,169
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 782731
    ROE Annual % 1218
    ROCE Annual % 1520
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1823
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 3,4402,9682,9033,0413,0792,5762,484
    Operating Expenses Qtr Cr 2,6932,5792,5492,4422,6252,3732,147
    Operating Profit Qtr Cr 747389353599454203337
    Depreciation Qtr Cr 74727878777683
    Interest Qtr Cr 30302927252717
    Tax Qtr Cr 3365144795520134
    Net Profit Qtr Cr 62128771455331128108
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 11,81510,797
    Operating Expenses Annual Cr 9,9908,581
    Operating Profit Annual in Cr 1,6092,053
    Depreciation Cr 310304
    Interest Annual Cr 10752
    Tax Annual Cr 298164
    Net Profit Annual Cr 9841,646
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 1,111
    Cash from Investing Activity Annual Cr -1,435
    Cash from Financing Annual Activity Cr 380
    Net Cash Flow Annual Cr 55
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 9,0458,638
    Fixed Assets Annual Cr 2,5932,838
    Total Non Current Assets Annual Cr 5,0275,634
    Total Current Assets Annual Cr 8,7308,435
    Total Assets Annual Cr 13,75714,069
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 789740
    ROE Annual % 1119
    ROCE Annual % 1521
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1621
    Invest in Alkem Laboratories

    Alkem Laboratories Technicals

    EMA & SMA

    Current Price
    ₹4,647.9
    -75.65 (-1.6%)
    pointer
    • Bullish Moving Average
    • ___
    • 16
    • Bearish Moving Average
    • ___
    • 0
    • 20 Day
    • ₹4,362.54
    • 50 Day
    • ₹4,064.23
    • 100 Day
    • ₹3,863.55
    • 200 Day
    • ₹3,662.56
    • 20 Day
    • ₹4,361.78
    • 50 Day
    • ₹3,903.23
    • 100 Day
    • ₹3,838.44
    • 200 Day
    • ₹3,587.72

    Alkem Laboratories Resistance and Support

    PIVOT
    ₹4,670.54
    Resistance
    First Resistance 4,719.32
    Second Resistance 4,790.73
    Third Resistance 4,839.52
    RSI 77.80
    MFI 82.69
    MACD Single Line 210.17
    MACD 221.02
    Support
    First Resistance 4,599.12
    Second Resistance 4,550.33
    Third Resistance 4,478.92

    Alkem Laboratories Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 274,692 19,555,323 71.19
    Week 302,606 19,327,461 63.87
    1 Month 332,132 16,237,929 48.89
    6 Month 211,450 12,240,842 57.89

    Alkem Laboratories Result Highlights

    Alkem Laboratories Synopsis

    NSE-Medical-Diversified

    Alkem Laboratories is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 9054.55 Cr. and Equity Capital is Rs. 23.91 Cr. for the Year ended 31/03/2023. Alkem Laboratories Ltd. is a Public Limited Listed company incorporated on 08/08/1973 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L00305MH1973PLC174201 and registration number is 174201.
    Market Cap 55,573
    Sales 9,422
    Shares in Float 5.14
    No of funds 242
    Yield 0.54
    Book Value 5.94
    U/D Vol ratio 2
    LTDebt / Equity
    Alpha 0.14
    Beta 0.57

    Alkem Laboratories

    Owner NameSep-23Jun-23Mar-23Dec-22
    Promoters 56.74%57.16%57.16%57.16%
    Mutual Funds 13.05%11.45%10.19%10.06%
    Insurance Companies 3.49%3.98%6%5.87%
    Foreign Portfolio Investors 6.03%5.63%4.44%4.41%
    Financial Institutions/ Banks
    Individual Investors 19.36%20.61%21.43%21.73%
    Others 1.33%1.17%0.78%0.77%

    Alkem Laboratories Management

    Name Designation
    Mr. Basudeo N Singh Executive Chairman
    Mr. Sandeep Singh Managing Director
    Mrs. Madhurima Singh Executive Director
    Mr. Balmiki Prasad Singh Executive Director
    Mr. Mritunjay Kumar Singh Executive Director
    Mr. Sarvesh Singh Executive Director
    Mr. Arun Kumar Purwar Independent Director
    Ms. Sangeeta Singh Independent Director
    Ms. Sudha Ravi Independent Director
    Dr. Dheeraj Sharma Independent Director
    Mr. Narendra Kumar Aneja Independent Director
    Mr. Sujjain Suresh Talwar Independent Director

    Alkem Laboratories Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Alkem Laboratories Corporate Action

    Date Purpose Remarks
    2023-11-07 Quarterly Results
    2023-08-10 Quarterly Results
    2023-05-19 Audited Results & Final Dividend
    2023-02-10 Quarterly Results & Interim Dividend
    2022-11-11 Quarterly Results
    Date Purpose Remarks
    2023-08-10 FINAL Rs.10.00 per share(500%)Final Dividend
    2023-02-18 INTERIM Rs.15.00 per share(750%)Interim Dividend
    2023-02-18 SPECIAL Rs.25.00 per share(1250%)Special Dividend
    2022-08-10 FINAL Rs.4.00 per share(200%)Final Dividend
    2022-02-12 INTERIM Rs.30.00 per share(1500%)Interim Dividend

    Alkem Laboratories MF Shareholding

    Name Amount(cr)
    ICICI Prudential Bluechip Fund Growth 41,269
    Kotak Emerging Equity Scheme Growth 33,700
    ICICI Prudential Value Discovery Fund Growth 32,494
    Kotak Equity Arbitrage Fund Growth 28,958
    ICICI Prudential Equity & Debt Fund Growth 26,183

    Alkem Laboratories FAQs

    What is Share Price of Alkem Laboratories ?

    Alkem Laboratories share price is ₹4,647 As on 04 December, 2023 | 02:40

    What is the Market Cap of Alkem Laboratories ?

    The Market Cap of Alkem Laboratories is ₹55572.6 Cr As on 04 December, 2023 | 02:40

    What is the P/E ratio of Alkem Laboratories ?

    The P/E ratio of Alkem Laboratories is 38.8 As on 04 December, 2023 | 02:40

    What is the PB ratio of Alkem Laboratories ?

    The PB ratio of Alkem Laboratories is 5.9 As on 04 December, 2023 | 02:40

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.